Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations

Area of Science:

• Neuroscience
• Psychiatry
• Radiology

Background:

• Serotonin 1A receptors (5-HT(1A)) are crucial in major depressive disorder (MDD) pathophysiology.
• Previous studies show conflicting results regarding 5-HT(1A) receptor binding potential (BP) in MDD patients.
• Discrepancies may stem from variations in study populations or methodological approaches.

Purpose of the Study:

• To replicate previous findings of altered 5-HT(1A) receptor BP in a novel cohort of MDD subjects.
• To investigate how the choice of reference region and outcome measure influences 5-HT(1A) BP measurements in MDD.
• To clarify the role of 5-HT(1A) receptors in MDD by addressing methodological inconsistencies.

Main Methods:

• Positron emission tomography (PET) scans were conducted on 22 not recently medicated (NRM) MDD subjects and 9 control subjects.
• Binding potential (BP) was assessed using both BP(F) (full reference tissue model) and BP(ND) (with cerebellar gray matter (CGM) and white matter (CWM) reference regions).
• Volume of distribution (V(T)) was also calculated to further analyze receptor kinetics.

Main Results:

• Higher 5-HT(1A) BP(F) was observed in NRM MDD subjects compared to controls (p = .0001), consistent with prior findings.
• BP(ND) using CWM reference region and V(T) did not differ between NRM MDD and control groups.
• Using CGM as a reference region, lower 5-HT(1A) BP(ND) (p = .03) and higher V(T) (p = .007) were found in NRM MDD subjects.

Conclusions:

• The selection of reference region and outcome measure critically affects 5-HT(1A) receptor findings in MDD.
• Higher 5-HT(1A) BP(F) in MDD is reliably detected using a method with minimal assumptions about non-specific binding.
• Employing a reference region devoid of 5-HT(1A) receptors is recommended for accurate BP(F) assessment in MDD research.